Radio(chemo)therapy in locally advanced nonsmall cell lung cancer

Definitive radiochemotherapy is the standard treatment for many patients with locally advanced nonsmall cell lung cancer (NSCLC). Treatment outcomes have improved over the last decades. Several treatment regimens have been shown effective and safe. This review summarises the results of significant s...

Full description

Bibliographic Details
Main Authors: Markus Glatzer, Olgun Elicin, Sara Ramella, Ursula Nestle, Paul Martin Putora
Format: Article
Language:English
Published: European Respiratory Society 2016-03-01
Series:European Respiratory Review
Online Access:http://err.ersjournals.com/content/25/139/65.full
_version_ 1828916650088333312
author Markus Glatzer
Olgun Elicin
Sara Ramella
Ursula Nestle
Paul Martin Putora
author_facet Markus Glatzer
Olgun Elicin
Sara Ramella
Ursula Nestle
Paul Martin Putora
author_sort Markus Glatzer
collection DOAJ
description Definitive radiochemotherapy is the standard treatment for many patients with locally advanced nonsmall cell lung cancer (NSCLC). Treatment outcomes have improved over the last decades. Several treatment regimens have been shown effective and safe. This review summarises the results of significant studies between 1996 and 2015 on concomitant and sequential radiochemotherapy regimens and radiation dose per fraction. Beside therapy regimens, optimised radiotherapy planning is indispensable to improve outcome and minimise radiation-induced toxicity. An insight into the rationale of radiotherapy planning for stage III NSCLC is also provided.
first_indexed 2024-12-13T20:36:45Z
format Article
id doaj.art-001735d50a864a72af1c45313ff70f1f
institution Directory Open Access Journal
issn 0905-9180
1600-0617
language English
last_indexed 2024-12-13T20:36:45Z
publishDate 2016-03-01
publisher European Respiratory Society
record_format Article
series European Respiratory Review
spelling doaj.art-001735d50a864a72af1c45313ff70f1f2022-12-21T23:32:16ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172016-03-0125139657010.1183/16000617.0053-20150053-2015Radio(chemo)therapy in locally advanced nonsmall cell lung cancerMarkus Glatzer0Olgun Elicin1Sara Ramella2Ursula Nestle3Paul Martin Putora4 Dept of Radiation Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland Dept of Radiation Oncology, University Hospital Bern, Bern, Switzerland Dept of Radiation Oncology, Campus Bio-Medico University, Rome, Italy Dept of Radiation Oncology, University Medical Center Freiburg, Freiburg, Germany Dept of Radiation Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland Definitive radiochemotherapy is the standard treatment for many patients with locally advanced nonsmall cell lung cancer (NSCLC). Treatment outcomes have improved over the last decades. Several treatment regimens have been shown effective and safe. This review summarises the results of significant studies between 1996 and 2015 on concomitant and sequential radiochemotherapy regimens and radiation dose per fraction. Beside therapy regimens, optimised radiotherapy planning is indispensable to improve outcome and minimise radiation-induced toxicity. An insight into the rationale of radiotherapy planning for stage III NSCLC is also provided.http://err.ersjournals.com/content/25/139/65.full
spellingShingle Markus Glatzer
Olgun Elicin
Sara Ramella
Ursula Nestle
Paul Martin Putora
Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
European Respiratory Review
title Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
title_full Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
title_fullStr Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
title_full_unstemmed Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
title_short Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
title_sort radio chemo therapy in locally advanced nonsmall cell lung cancer
url http://err.ersjournals.com/content/25/139/65.full
work_keys_str_mv AT markusglatzer radiochemotherapyinlocallyadvancednonsmallcelllungcancer
AT olgunelicin radiochemotherapyinlocallyadvancednonsmallcelllungcancer
AT sararamella radiochemotherapyinlocallyadvancednonsmallcelllungcancer
AT ursulanestle radiochemotherapyinlocallyadvancednonsmallcelllungcancer
AT paulmartinputora radiochemotherapyinlocallyadvancednonsmallcelllungcancer